In a highly anticipated meeting of the agency’s vaccine advisory board, some said that the current guidelines, which require two months of safety data after a volunteer has been vaccinated, were not enough.
All the weak points of American health care — testing delays, communication breakdowns, inequity — are working against this potential treatment.
Katie ThomasAntibody treatments like the one that President Trump got are promising, but the rollout will be tough. All of the factors that have bedeviled the American response so far -- testing delays, confusion, inequities -- could make it tougher.
How the world’s greatest public health organization was brought to its knees by a virus, the president and the capitulation of its own leaders, causing damage that could last much longer than the coronavirus.
Katie ThomasEmployees spoke openly about their “hill to die on” — the political interference that would prompt them to leave. Yet again and again, they surrendered and did as they were told.
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
Katie ThomasWhat if we had a treatment not just for Covid-19, but that also protected against SARS and future coronaviruses? @apoorva_nyc with the story of one team of scientists working to do just that
Katie ThomasThe antibody cocktail that President Trump touted on Wednesday afternoon was developed with cells originally derived from fetal tissue, a practice the president has repeatedly condemned. By @apoorva_nyc
The company said that doses of the unproven treatment would be available for 50,000 patients. It’s impossible to know whether it helped the president.
Katie ThomasInterrupting debate coverage with some breaking news: Regeneron has submitted an emergency application for authorization of the antibody cocktail that President Trump claimed without evidence is a "cure."